Monthly Archives: February 2021

Ebang International announces closing of follow-up public offering and exercise of warrants for gross proceeds of approximately $ 72.4 million

HANGZHOU, China, February 22, 2021 (GLOBE NEWSWIRE) – Ebang International Holdings Inc. (Nasdaq: EBON, the “Company”, “we” or “our”), a blockchain technology company in the global market, announced today ‘hui the completion of the offer previously announced by and between the Company and several institutional investors (the “Investors”), and the …

Read More »

The initial public offering boom is expected to continue until 2021

Related practices and jurisdictions Tuesday, February 16, 2021 Despite the uncertainty of 2020, initial public offerings (IPOs) in the United States set records in 2020, recording 407 IPOs which raised a total of $ 145 billion. The 2020 IPO boom more than doubled the 195 IPOs recorded in 2019, which …

Read More »

InspireMD Announces Closing of $ 20.7 Million Public Offering and Full Exercise of Over-Allotment Option

TEL AVIV, Israel, February 8, 2021 (GLOBE NEWSWIRE) – InspireMD, Inc. (“InspireMD”) (NYSE:NSPR), a medical device company focused on the development and commercialization of the proprietary MicroNet stent platform technology for the treatment of vascular and coronary heart disease in Europe, Latin America, the Middle East and Asia, has announced …

Read More »

Bioventus Announces Initial Public Offering of Class A Common Shares

06 February 2021 1 min read ADD A SUBJECT TO E-MAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “data-action =” subscribe “> Subscribe We have not been able to process your …

Read More »

InspireMD announces the price of an increased public offering of $ 18 million

TEL AVIV, Israel, February 04, 2021 (GLOBE NEWSWIRE) – InspireMD, Inc. (“InspireMD”) (NYSE:NSPR), a medical device company focused on the development and commercialization of the proprietary MicroNet stent platform technology for the treatment of vascular and coronary heart disease in Europe, Latin America, the Middle East and Asia, has announced …

Read More »